Ticagrelor is
Ticagrelor is a novel, potent, reversible platelet P2Y12 inhibitor. It is shown to reduce the risk of cardiovascular death, MI, or stroke compared with clopidogrel in ACS patients.This agent reduced moality but increased the risk of bleeding.Other platelets P2Y12 receptor blocker are clopidogrel, prasugrel.Ref: Harrison 19e pg: 1596
Cyclooxygenase inhibitors
Phosphodiesterase inhibitors
Glycoprotein IIB/IIIA inhibitors
P2Y12 receptor blocker
C.V.S